CTOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Phathom Pharmaceuticals raised $50M on 05/15/2019
Phathom Pharmaceuticals raised $90M on 05/15/2019

Similar Companies

Clinical Match

Clinical Match™ is a physician-founded community of clinical investigators, patients, volunteers, and providers working towards the advancement of medicine.

Sunovion Pharmaceuticals

Sunovion Pharmaceuticals Inc. leads the way to a healthier tomorrow by creating medicines for respiratory diseases and central nervous system disorders.

Modus Health

Xeris Pharmaceuticals

It`s all about the experience. Everything we do is about simplifying and making things better and easier. It`s about making a difference in people`s lives.

Valeant Canada Limited

Valeant Canada Limited is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.